| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
36,984 |
30,852 |
$1.29M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,345 |
6,870 |
$562K |
| 95911 |
|
5,058 |
4,010 |
$425K |
| 95886 |
|
5,024 |
3,277 |
$342K |
| 95715 |
|
407 |
111 |
$301K |
| 95816 |
|
996 |
768 |
$160K |
| 27096 |
|
1,568 |
1,257 |
$82K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,502 |
3,130 |
$71K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,208 |
1,103 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
527 |
459 |
$51K |
| 72131 |
|
1,162 |
958 |
$48K |
| 95720 |
|
379 |
106 |
$42K |
| 95700 |
|
138 |
107 |
$25K |
| 20610 |
|
597 |
496 |
$19K |
| 99406 |
|
1,270 |
1,138 |
$14K |
| 72192 |
|
679 |
539 |
$14K |
| 95861 |
|
476 |
371 |
$13K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,568 |
2,120 |
$10K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
190 |
159 |
$10K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
26 |
25 |
$6K |
| 95957 |
|
33 |
28 |
$5K |
| 87632 |
|
40 |
40 |
$4K |
| 93229 |
|
18 |
12 |
$4K |
| 95970 |
|
318 |
257 |
$4K |
| 95925 |
|
261 |
214 |
$4K |
| 95926 |
|
424 |
335 |
$3K |
| 73700 |
|
82 |
59 |
$3K |
| 73200 |
|
62 |
52 |
$3K |
| 95930 |
|
55 |
45 |
$2K |
| 95812 |
|
18 |
12 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
71 |
70 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
160 |
138 |
$2K |
| 87486 |
|
71 |
70 |
$1K |
| 87581 |
|
70 |
69 |
$1K |
| 95953 |
|
21 |
14 |
$1K |
| 92653 |
|
144 |
101 |
$1K |
| 93224 |
|
16 |
12 |
$640.99 |
| 96132 |
|
16 |
15 |
$567.41 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
21 |
21 |
$385.99 |
| 93040 |
|
35 |
29 |
$224.32 |
| 96139 |
|
15 |
14 |
$152.44 |
| 96138 |
|
15 |
14 |
$151.13 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
41 |
36 |
$147.54 |
| 93228 |
|
18 |
12 |
$136.60 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
202 |
129 |
$0.72 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,422 |
1,209 |
$0.00 |
| 99408 |
|
41 |
37 |
$0.00 |
| 99490 |
Ccm add 20min |
233 |
156 |
$0.00 |
| 91320 |
|
172 |
117 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
429 |
340 |
$0.00 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
697 |
543 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
732 |
569 |
$0.00 |
| G9561 |
Patients prescribed opiates for longer than six weeks |
776 |
610 |
$0.00 |
| 91322 |
|
75 |
72 |
$0.00 |
| 4004F |
|
356 |
277 |
$0.00 |
| 77003 |
|
110 |
76 |
$0.00 |
| 90661 |
|
43 |
25 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
95 |
69 |
$0.00 |
| 90653 |
|
105 |
103 |
$0.00 |
| 90658 |
|
18 |
18 |
$0.00 |
| G2058 |
Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). |
159 |
102 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
159 |
137 |
$0.00 |
| G9583 |
Patients prescribed opiates for longer than six weeks |
789 |
616 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
26 |
13 |
$0.00 |
| 1036F |
|
220 |
164 |
$0.00 |
| 90480 |
|
276 |
212 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
267 |
206 |
$0.00 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
147 |
140 |
$0.00 |
| 1006F |
|
38 |
33 |
$0.00 |
| 90677 |
|
26 |
14 |
$0.00 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
12 |
12 |
$0.00 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
14 |
12 |
$0.00 |